Sirturo Interactions
There are 569 drugs known to interact with Sirturo (bedaquiline), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 232 are major, 335 are moderate, and 2 are minor.
- View all 569 medications that may interact with Sirturo
- View Sirturo alcohol/food interactions (1)
- View Sirturo disease interactions (5)
Most frequently checked interactions
View interaction reports for Sirturo (bedaquiline) and the medicines listed below.
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Advate (antihemophilic factor)
- Afinitor Disperz (everolimus)
- Alimta (pemetrexed)
- Arava (leflunomide)
- Austedo (deutetrabenazine)
- azithromycin
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Baraclude (entecavir)
- Bosulif (bosutinib)
- Cathflo Activase (alteplase)
- Cayston (aztreonam)
- Celebrex (celecoxib)
- Celestone Soluspan (betamethasone)
- Cerezyme (imiglucerase)
- Copaxone (glatiramer)
- Corlanor (ivabradine)
- Creon (pancrelipase)
- Crixivan (indinavir)
- Cymbalta (duloxetine)
- Cytoxan (cyclophosphamide)
- Dibenzyline (phenoxybenzamine)
- Inderal (propranolol)
- Jynarque (tolvaptan)
- Kynamro (mipomersen)
- Nydrazid (isoniazid)
- Videx (didanosine)
- Zelapar (selegiline)
Sirturo alcohol/food interactions
There is 1 alcohol/food interaction with Sirturo (bedaquiline).
Sirturo disease interactions
There are 5 disease interactions with Sirturo (bedaquiline) which include:
More about Sirturo (bedaquiline)
- Sirturo consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: diarylquinolines
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.